Corbevex expected to get WHO prequalification, says Mahima Datla – ET HealthWorld
Hyderabad: Biological E’s COVID-19 vaccine candidate, Corbevex, is expected to get the World Health Organisation‘s (WHO) prequalification over the next…
Mahima Datla
Continue reading
Corbevex expected to get WHO prequalification, says Mahima Datla – ET HealthWorld
Hyderabad: Biological E’s COVID-19 vaccine candidate, Corbevex, is expected to get the World Health Organisation‘s (WHO) prequalification over the next…
Covid-19 story not yet done: Mahima Datla – ET HealthWorld
Hyderabad: Vaccine maker Biological E‘s expects to get World Health Organisation (WHO) prequalification for its protein subunit Covid-19 vaccine Corbevax…
Telangana buoyed by Flanders, gives wing to lifesciences ecosystem – ET HealthWorld
Hyderabad: As part of efforts to explore multiple collaboration opportunities in the lifesciences sector, the Telangana government has constituted an…
Biological E plans to hive off non-vaccine business and sell stake – ET HealthWorld
Biological E (BE) said it is actively exploring the option of hiving off its non-vaccine business into a separate entity…
SEC recommends Bio E’s 14-valent pneumococcal conjugate vaccine PCV14 for infants – ET HealthWorld
Hyderabad: Vaccine maker Biological E Limited (BE) on Thursday said the Subject Expert Committee (SEC) of the Central Drugs Standard…
Biological E’s CORBEVAX receives EUA for 5-12-year age group – ET HealthWorld
Hyderabad: Biological E Limited (BE) announced that its COVID-19 vaccine CORBEVAX has received a nod from the Drugs Controller General…
“Most Affordable”: Biological E Chief On Kids’ Vaccine Corbevax
Corbevax was launched today for 12-to 14-year-olds in the country. New Delhi: Mahima Datla, the MD of Biological E —…
India’s Biological E. to produce Johnson & Johnson’s Covid-19 vaccine – ET HealthWorld
India’s Biological E. will produce the Johnson & Johnson Covid-19 vaccine alongside its own candidate, its managing director told Reuters…